chr16-2300067-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001089.3(ABCA3):c.1549G>A(p.Glu517Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000201 in 1,613,684 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00038 ( 1 hom., cov: 30)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
ABCA3
NM_001089.3 missense
NM_001089.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.42
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.025774598).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA3 | NM_001089.3 | c.1549G>A | p.Glu517Lys | missense_variant | 13/33 | ENST00000301732.10 | NP_001080.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA3 | ENST00000301732.10 | c.1549G>A | p.Glu517Lys | missense_variant | 13/33 | 1 | NM_001089.3 | ENSP00000301732 | P1 | |
ABCA3 | ENST00000382381.7 | c.1375G>A | p.Glu459Lys | missense_variant | 12/32 | 1 | ENSP00000371818 | |||
ABCA3 | ENST00000563623.5 | n.2112G>A | non_coding_transcript_exon_variant | 13/20 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000382 AC: 58AN: 151770Hom.: 1 Cov.: 30
GnomAD3 genomes
AF:
AC:
58
AN:
151770
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251444Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135902
GnomAD3 exomes
AF:
AC:
51
AN:
251444
Hom.:
AF XY:
AC XY:
27
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000182 AC: 266AN: 1461796Hom.: 0 Cov.: 32 AF XY: 0.000166 AC XY: 121AN XY: 727190
GnomAD4 exome
AF:
AC:
266
AN:
1461796
Hom.:
Cov.:
32
AF XY:
AC XY:
121
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000382 AC: 58AN: 151888Hom.: 1 Cov.: 30 AF XY: 0.000445 AC XY: 33AN XY: 74234
GnomAD4 genome
AF:
AC:
58
AN:
151888
Hom.:
Cov.:
30
AF XY:
AC XY:
33
AN XY:
74234
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
20
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 08, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Glu517Lys varia nt in ABCA3 has not been previously identified in individuals with pulmonary dis ease. This variant has been identified in 1/8600 European American chromosomes b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP r s201157181). Glutamic acid (Glu) at position 517 is poorly conserved in evolutio n and at least 2 mammals (tarsier and alpaca) carry the variant amino acid, rais ing the possibility that this change may be tolerated. Additional computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) sug gest that the Glu517Lys variant may not impact the protein, though this informat ion is not predictive enough to rule out pathogenicity. In summary, this variant is less likely disease causing but additional information is needed to fully as sess its clinical significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at